TP53 and prostate carcinoma: In this study, we investigated the causal relationship between enzymes in Glutathione metabolism and prostate cancer based on public databases; GSTP1 has the potential to serve as a biomarker for prostate cancer and may inhibit the development of prostate cancer through interactions between immune cells or upregulation of the P53 pathway and apoptosis.